iCAD, Inc. (ICAD)
NASDAQ: ICAD · Real-Time Price · USD
1.545
-0.015 (-0.96%)
At close: Nov 20, 2024, 4:00 PM
1.580
+0.035 (2.27%)
After-hours: Nov 20, 2024, 6:49 PM EST
iCAD, Inc. Market Cap
iCAD, Inc. has a market cap or net worth of $40.72 million as of November 21, 2024. Its market cap has increased by 8.00% in one year.
Market Cap
40.72M
Enterprise Value
22.34M
1-Year Change
8.00%
Ranking
Category
Stock Price
$1.55
Market Cap Chart
Since December 1, 1998, iCAD, Inc.'s market cap has increased from $12.80M to $40.72M, an increase of 218.10%. That is a compound annual growth rate of 4.55%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 20, 2024 | 41.00M | -12.02% |
Dec 29, 2023 | 46.60M | - |
Dec 30, 2022 | 46.60M | -74.23% |
Dec 31, 2021 | 180.80M | -40.43% |
Dec 31, 2020 | 303.50M | 101.80% |
Dec 31, 2019 | 150.40M | 142.19% |
Dec 31, 2018 | 62.10M | 9.33% |
Dec 29, 2017 | 56.80M | 9.44% |
Dec 30, 2016 | 51.90M | -36.16% |
Dec 31, 2015 | 81.30M | -42.95% |
Dec 31, 2014 | 142.50M | 12.65% |
Dec 31, 2013 | 126.50M | 140.04% |
Dec 31, 2012 | 52.70M | 68.91% |
Dec 30, 2011 | 31.20M | -49.76% |
Dec 31, 2010 | 62.10M | -10.52% |
Dec 31, 2009 | 69.40M | 35.55% |
Dec 31, 2008 | 51.20M | -35.92% |
Dec 31, 2007 | 79.90M | -26.63% |
Dec 29, 2006 | 108.90M | 153.26% |
Dec 30, 2005 | 43.00M | -71.90% |
Dec 31, 2004 | 153.00M | 5.66% |
Dec 31, 2003 | 144.80M | 119.73% |
Dec 31, 2002 | 65.90M | 212.32% |
Dec 31, 2001 | 21.10M | -50.93% |
Dec 29, 2000 | 43.00M | 35.22% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Omega Therapeutics | 41.92M |
HCW Biologics | 41.61M |
Accelerate Diagnostics | 41.44M |
Intensity Therapeutics | 41.32M |
Envoy Medical | 41.30M |
Nexalin Technology | 41.08M |
LAVA Therapeutics | 40.89M |
NeueHealth | 40.77M |